Committee on Rules of Practice and Procedure; Meeting of the Judicial Conference, 59189 [2021-23276]
Download as PDF
59189
Federal Register / Vol. 86, No. 204 / Tuesday, October 26, 2021 / Notices
importers of the products at issue in this
investigation. The initial written
submissions and proposed remedial
orders must be filed no later than close
of business on Wednesday, November 3,
2021. Reply submissions must be filed
no later than the close of business on
Wednesday, November 10, 2021. No
further submissions on these issues will
be permitted unless otherwise ordered
by the Commission.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above. The Commission’s paper
filing requirements in 19 CFR 210.4(f)
are currently waived. 85 FR 15798
(March 19, 2020). Submissions should
refer to the investigation number (Inv.
No. 337–TA–1206) in a prominent place
on the cover page and/or the first page.
(See Handbook for Electronic Filing
Procedures, https://www.usitc.gov/
documents/handbook_on_filing_
procedures.pdf). Persons with questions
regarding filing should contact the
Secretary, (202) 205–2000.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment by marking each document
with a header indicating that the
document contains confidential
information. This marking will be
deemed to satisfy the request procedure
set forth in Rules 201.6(b) and
210.5(e)(2) (19 CFR 201.6(b) &
210.5(e)(2)). Documents for which
confidential treatment by the
Commission is properly sought will be
treated accordingly. A redacted nonconfidential version of the document
must also be filed simultaneously with
any confidential filing. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel, solely for cybersecurity
purposes. All contract personnel will
sign appropriate nondisclosure
agreements. All nonconfidential written
submissions will be available for public
inspection on EDIS.
The Commission vote for this
determination took place on October 20,
2021.
VerDate Sep<11>2014
22:39 Oct 25, 2021
Jkt 256001
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended, 19 U.S.C. 1337, and in Part
210 of the Commission’s Rules of
Practice and Procedure, 19 CFR part
210.
DEPARTMENT OF JUSTICE
By order of the Commission.
Issued: October 20, 2021.
Lisa Barton,
Secretary to the Commission.
AGENCY:
JUDICIAL CONFERENCE OF THE
UNITED STATES
Committee on Rules of Practice and
Procedure; Meeting of the Judicial
Conference
Judicial Conference of the
United States.
AGENCY:
Committee on Rules of Practice
and Procedure; revised notice of open
meeting.
ACTION:
The Committee on Rules of
Practice and Procedure will hold a
meeting in Washington, DC on January
4, 2022 rather than in Miami, FL as
previously announced. The meeting is
open to the public for observation but
not participation. An agenda and
supporting materials will be posted at
least 7 days in advance of the meeting
at: https://www.uscourts.gov/rulespolicies/records-and-archives-rulescommittees/agenda-books. The
announcement for this meeting was
previously published in the Federal
Register on June 28, 2021.
SUMMARY:
January 4, 2022.
FOR FURTHER INFORMATION CONTACT:
Scott Myers, Esq., Acting Chief Counsel,
Rules Committee Staff, Administrative
Office of the U.S. Courts, Thurgood
Marshall Federal Judiciary Building,
One Columbus Circle NE, Suite 7–300,
Washington, DC 20544, Phone (202)
502–1820, RulesCommittee_Secretary@
ao.uscourts.gov.
(Authority: 28 U.S.C. 2073.)
Dated: October 21, 2021.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
[FR Doc. 2021–23276 Filed 10–25–21; 8:45 am]
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Importer of Controlled Substances
Application: Globyz Pharma, LLC
Globyz Pharma, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTAL
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 26, 2021. Such
persons may also file a written request
for a hearing on the application on or
before November 26, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on August 18, 2021,
Globyz Pharma, LLC, 2101 Market
Street, Suite 5, Upper Chichester,
Pennsylvania 19061–4001, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUMMARY:
BILLING CODE 7020–02–P
BILLING CODE 2210–55–P
[Docket No. DEA–917]
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
[FR Doc. 2021–23267 Filed 10–25–21; 8:45 am]
DATES:
Drug Enforcement Administration
Controlled substance
Amphetamine ..................
Lisdexamfetamine ...........
Oxycodone ......................
I
Drug
code
Schedule
1100
1205
9143
II
II
II
I
The company plans to import finished
dosage unit products of the above
controlled substances solely for its
customers to perform analytical testing
to meet Canadian requirements. The
analysis is required to allow its
customers to export domestically
E:\FR\FM\26OCN1.SGM
26OCN1
Agencies
[Federal Register Volume 86, Number 204 (Tuesday, October 26, 2021)]
[Notices]
[Page 59189]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23276]
=======================================================================
-----------------------------------------------------------------------
JUDICIAL CONFERENCE OF THE UNITED STATES
Committee on Rules of Practice and Procedure; Meeting of the
Judicial Conference
AGENCY: Judicial Conference of the United States.
ACTION: Committee on Rules of Practice and Procedure; revised notice of
open meeting.
-----------------------------------------------------------------------
SUMMARY: The Committee on Rules of Practice and Procedure will hold a
meeting in Washington, DC on January 4, 2022 rather than in Miami, FL
as previously announced. The meeting is open to the public for
observation but not participation. An agenda and supporting materials
will be posted at least 7 days in advance of the meeting at: https://www.uscourts.gov/rules-policies/records-and-archives-rules-committees/agenda-books. The announcement for this meeting was previously
published in the Federal Register on June 28, 2021.
DATES: January 4, 2022.
FOR FURTHER INFORMATION CONTACT: Scott Myers, Esq., Acting Chief
Counsel, Rules Committee Staff, Administrative Office of the U.S.
Courts, Thurgood Marshall Federal Judiciary Building, One Columbus
Circle NE, Suite 7-300, Washington, DC 20544, Phone (202) 502-1820,
[email protected].
(Authority: 28 U.S.C. 2073.)
Dated: October 21, 2021.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
[FR Doc. 2021-23276 Filed 10-25-21; 8:45 am]
BILLING CODE 2210-55-P